Cite
Mealing NM, Dobbins TA, Pearson SA. Validation and application of a death proxy in adult cancer patients. Pharmacoepidemiol Drug Saf. 2011;21(7):742-748doi: 10.1002/pds.2257.
Mealing, N. M., Dobbins, T. A., & Pearson, S. A. (2012). Validation and application of a death proxy in adult cancer patients. Pharmacoepidemiology and drug safety, 21(7), 742-748. https://doi.org/10.1002/pds.2257
Mealing, Nicole M, et al. "Validation and application of a death proxy in adult cancer patients." Pharmacoepidemiology and drug safety vol. 21,7 (2012): 742-748. doi: https://doi.org/10.1002/pds.2257
Mealing NM, Dobbins TA, Pearson SA. Validation and application of a death proxy in adult cancer patients. Pharmacoepidemiol Drug Saf. 2012 Jul;21(7):742-748. doi: 10.1002/pds.2257. Epub 2011 Oct 21. PMID: 22020956.
Copy
Download .nbib